Statins, the most widely prescribed drugs worldwide, are often suggested to lower cholesterol and prevent heart disease in individuals with obesity, diabetes and metabolic syndrome, which is a combination of medical disorders ...
May 15, 2013
0
0
Inherited ventricular arrhythmias are an important cause of morbidity and sudden cardiac death in children who have structurally normal hearts. Despite conventional medical therapy, some of these children remain symptomatic ...
May 7, 2013
0
0
Researchers from Murdoch University's School of Health Professions are urging health organisations to reconsider their attitudes to mothers and babies bedsharing.
Apr 29, 2013
0
0
According to a study published in the Journals of Gerontology Series A: Biological Sciences and Medical Sciences, a baseline adherence to a Mediterranean diet (MeDiet) is associated with a lower risk of hyperuricemia, defined ...
Apr 18, 2013
0
0
(HealthDay)—Even people who are slightly obese could be candidates for weight-loss surgery under new guidelines released by three U.S. medical groups.
Apr 17, 2013
1
0
The American College of Physicians (ACP) today unveiled two evidence-based interventions and two videos to improve the health outcomes of patients in the first year following an initial acute coronary syndrome (ACS) event ...
Apr 12, 2013
0
0
(Medical Xpress)—University of Otago researchers have discovered a potential new tool to help doctors in emergency departments quickly and accurately diagnose patients with heart failure and pneumonia.
Apr 3, 2013
0
0
Energy drinks may increase blood pressure and disturb your heart's natural rhythm, according to research presented at the American Heart Association's Epidemiology and Prevention/Nutrition, Physical Activity and Metabolism ...
Mar 21, 2013
0
0
Researchers at the University of Southampton are planning to investigate tests for a breathing disorder that affects babies and children who have Down syndrome while they sleep. They aim to provide the missing evidence so ...
Mar 14, 2013
0
0
A single dose of an investigational anti-inflammatory drug, inclacumab, reduced damage to heart tissue during angioplasty in a study presented today at the American College of Cardiology's 62nd Annual Scientific Session.
Mar 12, 2013
1
0
